Your browser doesn't support javascript.
loading
Can therapeutic drug monitoring increase the safety of Imatinib in GIST patients?
Zhuang, Wei; Xie, Jing-Dun; Zhou, Shan; Zhou, Zhi-Wei; Zhou, Yi; Sun, Xiao-Wei; Yuan, Xiu-Hong; Huang, Min; Liu, Si; Xin, Shuang; Su, Qi-Biao; Qiu, Hai-Bo; Wang, Xue-Ding.
Afiliação
  • Zhuang W; Institute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, China.
  • Xie JD; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
  • Zhou S; Institute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, China.
  • Zhou ZW; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
  • Zhou Y; The first affiliated hospital, Sun Yat-Sen University, Guangzhou, 510080, China.
  • Sun XW; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
  • Yuan XH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
  • Huang M; Institute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, China.
  • Liu S; Institute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, China.
  • Xin S; Institute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, China.
  • Su QB; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
  • Qiu HB; College of health science, Guangdong Pharmaceutical University, Guangzhou, Guangzhou, 510006, China.
  • Wang XD; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Cancer Med ; 7(2): 317-324, 2018 02.
Article em En | MEDLINE | ID: mdl-29316372
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Monitoramento de Medicamentos / Mielopoese / Tumores do Estroma Gastrointestinal / Mesilato de Imatinib / Neoplasias Gastrointestinais / Leucopenia / Antineoplásicos Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Monitoramento de Medicamentos / Mielopoese / Tumores do Estroma Gastrointestinal / Mesilato de Imatinib / Neoplasias Gastrointestinais / Leucopenia / Antineoplásicos Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China